BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 18364000)

  • 1. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
    Allavena P; Sica A; Garlanda C; Mantovani A
    Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.
    Mantovani A; Sica A; Allavena P; Garlanda C; Locati M
    Hum Immunol; 2009 May; 70(5):325-30. PubMed ID: 19236898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site.
    Laoui D; Van Overmeire E; Movahedi K; Van den Bossche J; Schouppe E; Mommer C; Nikolaou A; Morias Y; De Baetselier P; Van Ginderachter JA
    Immunobiology; 2011 Nov; 216(11):1192-202. PubMed ID: 21803441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways connecting inflammation and cancer.
    Allavena P; Garlanda C; Borrello MG; Sica A; Mantovani A
    Curr Opin Genet Dev; 2008 Feb; 18(1):3-10. PubMed ID: 18325755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
    Apte RN; Voronov E
    Immunol Rev; 2008 Apr; 222():222-41. PubMed ID: 18364005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer related inflammation: the macrophage connection.
    Sica A; Allavena P; Mantovani A
    Cancer Lett; 2008 Aug; 267(2):204-15. PubMed ID: 18448242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergent pathways of macrophage polarization: The role of B cells.
    Sica A; Porta C; Riboldi E; Locati M
    Eur J Immunol; 2010 Aug; 40(8):2131-3. PubMed ID: 20623553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenesis and immune suppression: yin and yang of tumor progression?].
    Szala S
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():598-612. PubMed ID: 20009124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swords into plowshares: IL-23 repurposes tumor immune surveillance.
    Langowski JL; Kastelein RA; Oft M
    Trends Immunol; 2007 May; 28(5):207-12. PubMed ID: 17395538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage polarization in tumour progression.
    Sica A; Larghi P; Mancino A; Rubino L; Porta C; Totaro MG; Rimoldi M; Biswas SK; Allavena P; Mantovani A
    Semin Cancer Biol; 2008 Oct; 18(5):349-55. PubMed ID: 18467122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
    Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
    J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-derived suppressor cell role in tumor-related inflammation.
    Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
    Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor associated macrophages and neutrophils in tumor progression.
    Galdiero MR; Garlanda C; Jaillon S; Marone G; Mantovani A
    J Cell Physiol; 2013 Jul; 228(7):1404-12. PubMed ID: 23065796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.
    Mantovani A; Allavena P; Sica A
    Eur J Cancer; 2004 Jul; 40(11):1660-7. PubMed ID: 15251154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.
    Solinas G; Germano G; Mantovani A; Allavena P
    J Leukoc Biol; 2009 Nov; 86(5):1065-73. PubMed ID: 19741157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages: foe or accomplice of tumors?
    Ohno S; Suzuki N; Ohno Y; Inagawa H; Soma G; Inoue M
    Anticancer Res; 2003; 23(6a):4395-409. PubMed ID: 14666727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages.
    Eriksson F; Tsagozis P; Lundberg K; Parsa R; Mangsbo SM; Persson MA; Harris RA; Pisa P
    J Immunol; 2009 Mar; 182(5):3105-11. PubMed ID: 19234207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
    Mantovani A; Sozzani S; Locati M; Schioppa T; Saccani A; Allavena P; Sica A
    Novartis Found Symp; 2004; 256():137-45; discussion 146-8, 259-69. PubMed ID: 15027487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.